- Home
- POCI vs ANEB Comparison
POCI vs ANEB Comparison
Compare POCI & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- ANEB
- Stock Information
- Founded
- POCI 1982
- ANEB 2020
- Country
- POCI United States
- ANEB United States
- Employees
- POCI N/A
- ANEB N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- ANEB Health Care
- Exchange
- POCI Nasdaq
- ANEB Nasdaq
- Market Cap
- POCI 32.9M
- ANEB 111.8M
- IPO Year
- POCI N/A
- ANEB 2021
- Fundamental
- Price
- POCI $4.30
- ANEB $2.64
- Analyst Decision
- POCI
- ANEB Buy
- Analyst Count
- POCI 0
- ANEB 2
- Target Price
- POCI N/A
- ANEB $8.00
- AVG Volume (30 Days)
- POCI 14.1K
- ANEB 20.2K
- Earning Date
- POCI 09-29-2025
- ANEB 11-14-2025
- Dividend Yield
- POCI N/A
- ANEB N/A
- EPS Growth
- POCI N/A
- ANEB N/A
- EPS
- POCI N/A
- ANEB N/A
- Revenue
- POCI $19,091,269.00
- ANEB N/A
- Revenue This Year
- POCI N/A
- ANEB N/A
- Revenue Next Year
- POCI N/A
- ANEB N/A
- P/E Ratio
- POCI N/A
- ANEB N/A
- Revenue Growth
- POCI N/A
- ANEB N/A
- 52 Week Low
- POCI $3.47
- ANEB $0.80
- 52 Week High
- POCI $5.48
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- POCI 48.96
- ANEB 55.13
- Support Level
- POCI $4.11
- ANEB $2.50
- Resistance Level
- POCI $4.30
- ANEB $2.76
- Average True Range (ATR)
- POCI 0.11
- ANEB 0.13
- MACD
- POCI 0.02
- ANEB 0.00
- Stochastic Oscillator
- POCI 80.10
- ANEB 61.82
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.